Systematic screening reveals a role for BRCA1 in the response to transcription-associated DNA damage

Sarah J Hill1, Thomas Rolland2, Guillaume Adelmant3

  • 1Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA; Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA;

Genes & Development
|September 4, 2014
PubMed

Insights

Researchers discovered new BRCA1 protein interactions, revealing its role in DNA damage response during transcription. This finding sheds light on BRCA1

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • BRCA1 is a critical tumor suppressor gene involved in breast and ovarian cancer.
  • The full spectrum of BRCA1 functions remains incompletely understood.
  • Identifying novel protein interactions can elucidate new cellular roles for BRCA1.

Purpose of the Study:

  • To identify new BRCA1 protein-interacting partners through systematic screening.
  • To investigate potential new functions of BRCA1, particularly in DNA damage response.
  • To explore the relevance of these interactions and functions in the context of cancer.

Main Methods:

  • Systematic screens were employed to identify BRCA1 protein-interacting partners.
  • Genetic interaction analyses were performed between BRCA1 and identified interactors.
  • The study examined BRCA1's role in transcription-associated DNA damage, including UV damage and R-loop stabilization.

Main Results:

  • New BRCA1 protein interactors were identified, including TONSL, SETX, TCEANC, and TCEA2.
  • Genetic interactions were confirmed between BRCA1 and several of these interactors, as well as TONSL interactors like the FACT complex.
  • A novel function for BRCA1 in responding to transcription-associated DNA damage was uncovered, specifically in transcription restart post-UV damage and in managing R-loop-induced DNA damage.

Conclusions:

  • BRCA1 plays a previously unrecognized role in the cellular response to transcription-associated DNA damage.
  • This new function involves transcription restart and the prevention or repair of R-loop-associated DNA damage, likely mediated by newly identified interactors.
  • Aberrant expression of these interactors in breast and ovarian cancers suggests this newly identified BRCA1 function is significant for its tumor suppressor activity.

Related Concept Videos